Development of a clinical assay to evaluate toll-like receptor function.
about
Toll-like receptor 7 and 9 defects in common variable immunodeficiency.Mere visual perception of other people's disease symptoms facilitates a more aggressive immune response.IKBKG (nuclear factor-kappa B essential modulator) mutation can be associated with opportunistic infection without impairing Toll-like receptor function.Variables to be controlled in the assessment of blood innate immune responses to Toll-like receptor stimulation.Characterization of Toll-like receptor-4 (TLR-4) in the spleen and thymus of Swiss albino mice and its modulation in experimental endotoxemia.Congenital alterations of NEMO glutamic acid 223 result in hypohidrotic ectodermal dysplasia and immunodeficiency with normal serum IgG levelsLack of effect of glutamine administration to boost the innate immune system response in trauma patients in the intensive care unitImmunodeficiency among children with recurrent invasive pneumococcal disease.BAY 41-2272, a soluble guanylate cyclase agonist, activates human mononuclear phagocytes.Polychromatic flow cytometric high-throughput assay to analyze the innate immune response to Toll-like receptor stimulation.Immune dysregulation in severe influenza.Toll-like receptors' pathway disturbances are associated with increased susceptibility to infections in humans.Addressing diagnostic challenges in primary immunodeficiencies: laboratory evaluation of Toll-like receptor- and NF-κB-mediated immune responses.Targeting neutrophils in sepsis.Development and Application of a Novel SPE-Method for Bioassay-Guided Fractionation of Marine Extracts.Expression of Toll-like receptor 2 is up-regulated in monocytes from patients with chronic obstructive pulmonary diseaseLPS and poly I:C induce chromatin modifications at a novel upstream region of the IL-23 p19 promoter.
P2860
Q34013669-91C36D8C-3CE4-443A-BDBD-741E8F2545FDQ34116211-7AFB54D5-2E3F-4855-9644-522E66DD1572Q34630390-AA63E475-D2B9-468B-A6A5-54DC309B8966Q34634401-8060210F-8D10-4E42-A40D-765091C3E856Q35156132-A1D40E90-E081-4898-9D8B-536F8750DC23Q35224190-5A6E15FE-96A5-4B61-8637-9F4377AF1710Q35561252-E4751785-C187-42F6-99F7-26874287E2AAQ35648903-90947535-079F-4AED-BB08-C1F6099047B7Q36166660-483050B0-9711-4309-AEFC-5FF96E9D843BQ36944446-30B9C8F5-4010-4785-AD55-C3F53A918056Q37232946-EBA88EFE-84F3-48A9-912B-E43864BCCD8FQ38140711-F9A71B77-7AE3-48AA-9954-5AFBC464A570Q38188634-E983B915-BA3F-4B18-A368-43F1DAECDB9EQ38215408-B3BEB219-377A-4400-A232-23606A0D5147Q40530861-C2DA16AE-0BB5-48AE-A17B-6DF5D0EA73D5Q41974760-DB8B1C5C-4488-49EE-A859-F43AD6FE6577Q42765333-B9C96366-B62A-467B-956F-78241493D3E9
P2860
Development of a clinical assay to evaluate toll-like receptor function.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Development of a clinical assay to evaluate toll-like receptor function.
@en
type
label
Development of a clinical assay to evaluate toll-like receptor function.
@en
prefLabel
Development of a clinical assay to evaluate toll-like receptor function.
@en
P2860
P1476
Development of a clinical assay to evaluate toll-like receptor function
@en
P2093
Raquel P Deering
P2860
P356
10.1128/CVI.13.1.68-76.2006
P577
2006-01-01T00:00:00Z